Exploring the Link Between Dry Eye and Migraine: From Eye to Brain

References

• McDonald M, Patel DA, Keith MS, Snedecor SJ. Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review. Ocul Surf. 2016;14(2):144–167. doi:10.1016/j.jtos.2015.11.00226733111
   PubMed Web of Science ®Google Scholar
• Younger DS. Epidemiology of migraine. Neurol Clin. 2016;34(4):849–861. doi:10.1016/j.ncl.2016.06.01127719997
   PubMed Web of Science ®Google Scholar
• Bonafede M, Sapra S, Shah N, Tepper S, Cappell K, Desai P. Direct and indirect healthcare resource utilization and costs among migraine patients in the United States. Headache. 2018;58(5):700–714. doi:10.1111/head.1327529446063
   PubMed Web of Science ®Google Scholar
• Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.00828736335
   PubMed Web of Science ®Google Scholar
• Kalangara JP, Galor A, Levitt RC, et al. Characteristics of ocular pain complaints in patients with idiopathic dry eye symptoms. Eye Contact Lens. 2017;43(3):192–198. doi:10.1097/ICL.000000000000024926925537
   PubMed Web of Science ®Google Scholar
• Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–365.28736337
   PubMed Web of Science ®Google Scholar
• Chalmers RL, Begley CG, Caffery B. Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Cont Lens Anterior Eye. 2010;33(2):55–60. doi:10.1016/j.clae.2009.12.01020093066
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615–621. doi:10.1001/archopht.118.5.61510815152
   PubMedGoogle Scholar
• Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010;128(1):94–101. doi:10.1001/archophthalmol.2009.35620065224
   PubMedGoogle Scholar
• Qazi Y, Hurwitz S, Khan S, Jurkunas UV, Dana R, Hamrah P. Validity and reliability of a Novel Ocular Pain Assessment Survey (OPAS) in quantifying and monitoring corneal and ocular surface pain. Ophthalmology. 2016;123(7):1458–1468. doi:10.1016/j.ophtha.2016.03.00627089999
   PubMed Web of Science ®Google Scholar
• Farhangi M, Feuer W, Galor A, et al. Modification of the Neuropathic Pain Symptom Inventory for use in eye pain (NPSI-Eye). Pain. 2019;160(7):1541–1550. doi:10.1097/j.pain.000000000000155230883524
   PubMed Web of Science ®Google Scholar
• Willcox MDP, Argueso P, Georgiev GA, et al. TFOS DEWS II tear film report. Ocul Surf. 2017;15(3):366–403.28736338
   PubMed Web of Science ®Google Scholar
• Nelson JD, Craig JP, Akpek EK, et al. TFOS DEWS II Introduction. Ocul Surf. 2017;15(3):269–275. doi:10.1016/j.jtos.2017.05.00528736334
   PubMed Web of Science ®Google Scholar
• Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology. 2017;124(11):S20–S26. doi:10.1016/j.ophtha.2017.05.03129055358
   PubMed Web of Science ®Google Scholar
• Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–574.28736342
   PubMed Web of Science ®Google Scholar
• Lanza NL, Valenzuela F, Perez VL, Galor A. The matrix metalloproteinase 9 point-of-care test in dry eye. Ocul Surf. 2016;14(2):189–195. doi:10.1016/j.jtos.2015.10.00426850527
   PubMed Web of Science ®Google Scholar
• Bartlett JD, Keith MS, Sudharshan L, Snedecor SJ. Associations between signs and symptoms of dry eye disease: a systematic review. Clin Ophthalmol (Auckland, NZ). 2015;9:1719–1730. doi:10.2147/OPTH.S89700
   PubMed Web of Science ®Google Scholar
• Ong ES, Felix ER, Levitt RC, Feuer WJ, Sarantopoulos CD, Galor A. Epidemiology of discordance between symptoms and signs of dry eye. Br J Ophthalmol. 2018;102(5):674–679. doi:10.1136/bjophthalmol-2017-31063328821553
   PubMed Web of Science ®Google Scholar
• Pouyeh B, Viteri E, Feuer W, et al. Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol. 2012;153(6):1061–1066 e1063. doi:10.1016/j.ajo.2011.11.03022330309
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110(7):1412–1419. doi:10.1016/S0161-6420(03)00462-712867401
   PubMed Web of Science ®Google Scholar
• Fernandez CA, Galor A, Arheart KL, et al. Dry eye syndrome, posttraumatic stress disorder, and depression in an older male veteran population. Invest Ophthalmol Vis Sci. 2013;54(5):3666–3672. doi:10.1167/iovs.13-1163523633658
   PubMed Web of Science ®Google Scholar
• Labbe A, Wang YX, Jie Y, Baudouin C, Jonas JB, Xu L. Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study. Br J Ophthalmol. 2013;97(11):1399–1403. doi:10.1136/bjophthalmol-2013-30383824013959
   PubMed Web of Science ®Google Scholar
• Au NH, Mather R, To A, Malvankar-Mehta MS. Sleep outcomes associated with dry eye disease: a systematic review and meta-analysis. Can J Ophthalmol. 2019;54(2):180–189. doi:10.1016/j.jcjo.2018.03.01330975341
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. doi:10.1177/0333102417738202
   PubMed Web of Science ®Google Scholar
• Burch RC, Buse DC, Lipton RB. Migraine: epidemiology, Burden, and Comorbidity. Neurol Clin. 2019;37(4):631–649. doi:10.1016/j.ncl.2019.06.00131563224
   PubMed Web of Science ®Google Scholar
• Leonardi M, Raggi A, Bussone G, D’Amico D. Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache. 2010;50(10):1576–1586. doi:10.1111/j.1526-4610.2010.01770.x21029083
   PubMed Web of Science ®Google Scholar
• Vo P, Fang J, Bilitou A, Laflamme AK, Gupta S. Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom. J Headache Pain. 2018;19. doi:10.1186/s10194-018-0907-6
   Web of Science ®Google Scholar
• Ozudogru S, Neufeld A, Katz BJ, et al. Reduced visual quality of life associated with migraine is most closely correlated with symptoms of dry eye. Headache. 2019;59(10):1714–1721. doi:10.1111/head.1366231557326
   PubMed Web of Science ®Google Scholar
• Yang S, Kim W, Kim HS, Na KS. Association between migraine and dry eye disease: a nationwide population-based study. Curr Eye Res. 2017;42(6):837–841. doi:10.1080/02713683.2016.126287628129001
   PubMed Web of Science ®Google Scholar
• Ismail OM, Poole ZB, Bierly SL, et al. Association between dry eye disease and migraine headaches in a large population-based study. JAMA Ophthalmol. 2019;137(5):532–536. doi:10.1001/jamaophthalmol.2019.017030844042
   PubMed Web of Science ®Google Scholar
• Wang TJ, Wang IJ, Hu CC, Lin HC. Comorbidities of dry eye disease: a nationwide population-based study. Acta Ophthalmol. 2012;90(7):663–668. doi:10.1111/j.1755-3768.2010.01993.x20809911
   PubMed Web of Science ®Google Scholar
• Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American migraine prevalence and prevention study. Headache. 2012;52(10):1456–1470. doi:10.1111/j.1526-4610.2012.02223.x22830411
   PubMed Web of Science ®Google Scholar
• Farhangi M, Diel RJ, Buse DC, et al. Individuals with migraine have a different dry eye symptom profile than individuals without migraine. Br J Ophthalmol. 2020;104(2):260–264. doi:10.1136/bjophthalmol-2018-31347131040130
   PubMed Web of Science ®Google Scholar
• Koktekir BE, Celik G, Karalezli A, Kal A. Dry eyes and migraines: is there really a correlation? Cornea. 2012;31(12):1414–1416. doi:10.1097/ICO.0b013e318247ec2a22710496
   PubMed Web of Science ®Google Scholar
• Sarac O, Kosekahya P, Yildiz Tasci Y, et al. The prevalence of dry eye and sjogren syndrome in patients with migraine. Ocul Immunol Inflamm. 2017;25(3):370–375. doi:10.3109/09273948.2015.113273926910594
   PubMed Web of Science ®Google Scholar
• Kinard KI, Smith AG, Singleton JR, et al. Chronic migraine is associated with reduced corneal nerve fiber density and symptoms of dry eye. Headache. 2015;55(4):543–549. doi:10.1111/head.1254725828778
   PubMed Web of Science ®Google Scholar
• Celikbilek A, Adam M. The relationship between dry eye and migraine. Acta Neurol Belg. 2015;115(3):329–333. doi:10.1007/s13760-014-0359-y25231463
   PubMed Web of Science ®Google Scholar
• Noseda R, Copenhagen D, Burstein R. Current understanding of photophobia, visual networks and headaches. Cephalalgia. 2018;39(13):1623–1634. doi:10.1177/033310241878475029940781
   PubMed Web of Science ®Google Scholar
• Galor A, Levitt RC, Felix ER, Sarantopoulos CD. What can photophobia tell us about dry eye? Expert Rev Ophthalmol. 2016;11(5):321–324. doi:10.1080/17469899.2016.122290528845186
   PubMed Web of Science ®Google Scholar
• Galor A, Zlotcavitch L, Walter SD, et al. Dry eye symptom severity and persistence are associated with symptoms of neuropathic pain. Br J Ophthalmol. 2015;99(5):665–668. doi:10.1136/bjophthalmol-2014-30605725336572
   PubMed Web of Science ®Google Scholar
• Munjal S, Singh P, Reed ML, et al. Most bothersome symptom in persons with migraine: results from the Migraine in America Symptoms and Treatment (MAST) study. Headache. 2020;60(2):416–429. doi:10.1111/head.1370831837007
   PubMed Web of Science ®Google Scholar
• Diel RJ, Hwang J, Kroeger ZA, et al. Photophobia and sensations of dryness in migraine patients occur independent of baseline tear volume and improve following botulinum toxin A injections. Br J Ophthalmol. 2019;103(8):1024–1029. doi:10.1136/bjophthalmol-2018-31264930269099
   PubMed Web of Science ®Google Scholar
• Diel RJ, Mehra D, Kardon R, Buse DC, Moulton E, Galor A. Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic pathway. Br J Ophthalmol. 2020;bjophthalmol-2020-316417.
   Web of Science ®Google Scholar
• Brennan KC, Pietrobon D, A systems neuroscience approach to migraine. Neuron. 2018;97(5):1004–1021. doi:10.1016/j.neuron.2018.01.02929518355
   PubMed Web of Science ®Google Scholar
• Okamoto K, Thompson R, Tashiro A, Chang Z, Bereiter DA. Bright light produces Fos-positive neurons in caudal trigeminal brainstem. Neuroscience. 2009;160(4):858–864. doi:10.1016/j.neuroscience.2009.03.00319285114
   PubMed Web of Science ®Google Scholar
• Marek V, Reboussin E, Dégardin-Chicaud J, et al. Implication of melanopsin and trigeminal neural pathways in blue light photosensitivity in vivo. Front Neurosci. 2019;13:497. doi:10.3389/fnins.2019.0049731178682
   PubMed Web of Science ®Google Scholar
• Burstein R, Noseda R, Fulton AB. Neurobiology of photophobia. J Neuroophthalmol. 2019;39(1):94–102. doi:10.1097/WNO.000000000000076630762717
   PubMed Web of Science ®Google Scholar
• Noseda R, Kainz V, Jakubowski M, et al. A neural mechanism for exacerbation of headache by light. Nat Neurosci. 2010;13(2):239–245. doi:10.1038/nn.247520062053
   PubMed Web of Science ®Google Scholar
• Wattiez A-S, Sowers LP, Russo AF. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opin Ther Targets. 2020;24(2):91–100. doi:10.1080/14728222.2020.172428532003253
   PubMed Web of Science ®Google Scholar
• Sowers LP, Wang M, Rea BJ, et al. Stimulation of posterior thalamic nuclei induces photophobic behavior in mice. Headache. 2020;60(9):1961–1981. doi:10.1111/head.1391732750230
   PubMed Web of Science ®Google Scholar
• Bernstein CA, Nir -R-R, Noseda R, et al. The migraine eye: distinct rod-driven retinal pathways’ response to dim light challenges the visual cortex hyperexcitability theory. Pain. 2019;160(3):569–578. doi:10.1097/j.pain.000000000000143430376534
   PubMed Web of Science ®Google Scholar
• Xue T, Do MTH, Riccio A, et al. Melanopsin signalling in mammalian iris and retina. Nature. 2011;479(7371):67–73. doi:10.1038/nature1056722051675
   PubMed Web of Science ®Google Scholar
• IASP terminology; 2018. Available from: http://www.iasp-pain.org/terminology. Accessed 222, 2021.
   Google Scholar
• Belmonte C. Pain, dryness, and itch sensations in eye surface disorders are defined by a balance between inflammation and sensory nerve injury. Cornea. 2019;38:S11–S24. doi:10.1097/ICO.000000000000211631490785
   PubMed Web of Science ®Google Scholar
• Joubert F, Acosta M, Gallar J, et al. Effects of corneal injury on ciliary nerve fibre activity and corneal nociception in mice: a behavioural and electrophysiological study. Eur J Pain. 2019;23(3):589–602. doi:10.1002/ejp.133230370980
   PubMed Web of Science ®Google Scholar
• Kovács I, Luna C, Quirce S, et al. Abnormal activity of corneal cold thermoreceptors underlies the unpleasant sensations in dry eye disease. Pain. 2016;157(2):399–417. doi:10.1097/j.pain.000000000000045526675826
   PubMed Web of Science ®Google Scholar
• Yang AY, Chow J, Liu J. Corneal innervation and sensation: the eye and beyond. Yale J Biol Med. 2018;91:13–21.29599653
   PubMed Web of Science ®Google Scholar
• Parra A, Madrid R, Echevarria D, et al. Ocular surface wetness is regulated by TRPM8-dependent cold thermoreceptors of the cornea. Nat Med. 2010;16(12):1396–1399. doi:10.1038/nm.226421076394
   PubMed Web of Science ®Google Scholar
• Rahman M, Okamoto K, Thompson R, Katagiri A, Bereiter DA. Sensitization of trigeminal brainstem pathways in a model for tear deficient dry eye. PAIN. 2015;156(5):942–950. doi:10.1097/j.pain.000000000000013525734990
   PubMed Web of Science ®Google Scholar
• Mehra D, Cohen NK, Galor A. Ocular surface pain: a narrative review. Ophthalmol Ther. 2020;9(3):1–21. doi:10.1007/s40123-020-00263-9
   PubMed Web of Science ®Google Scholar
• Galor A, Felix ER, Feuer W, Levitt RC, Sarantopoulos CD. Corneal nerve pathway function in individuals with dry eye symptoms. Ophthalmology. 2020. doi:10.1016/j.ophtha.2020.07.061
   Web of Science ®Google Scholar
• Patel S, Hwang J, Mehra D, Galor A. Corneal nerve abnormalities in ocular and systemic diseases. Exp Eye Res. 2020;202:108284. doi:10.1016/j.exer.2020.10828433045221
   PubMed Web of Science ®Google Scholar
• Kowtharapu BS, Winter K, Marfurt C, et al. Comparative quantitative assessment of the human corneal sub-basal nerve plexus by in vivo confocal microscopy and histological staining. Eye. 2017;31(3):481–490. doi:10.1038/eye.2016.22027813513
   PubMed Web of Science ®Google Scholar
• Harte SE, Harris RE, Clauw DJ. The neurobiology of central sensitization. J Appl Biobehav Res. 2018;23(2):e12137.
   Web of Science ®Google Scholar
• Moulton EA, Becerra L, Borsook D. An fMRI case report of photophobia: activation of the trigeminal nociceptive pathway. Pain. 2009;145(3):358–363. doi:10.1016/j.pain.2009.07.01819674842
   PubMed Web of Science ®Google Scholar
• Galor A, Levitt RC, McManus KT, et al. Assessment of somatosensory function in patients with idiopathic dry eye symptoms. JAMA Ophthalmol. 2016;134(11):1290–1298. doi:10.1001/jamaophthalmol.2016.364227685701
   PubMed Web of Science ®Google Scholar
• Galor A, Moein H-R, Lee C, et al. Neuropathic pain and dry eye. Ocul Surf. 2018;16:31–44. doi:10.1016/j.jtos.2017.10.00129031645
   PubMed Web of Science ®Google Scholar
• Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. 2015;35(17):6619–6629. doi:10.1523/JNEUROSCI.0373-15.201525926442
   PubMed Web of Science ®Google Scholar
• Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018;17(2):174–182. doi:10.1016/S1474-4422(17)30435-029229375
   PubMed Web of Science ®Google Scholar
• Fakih D, Zhao Z, Nicolle P, et al. Chronic dry eye induced corneal hypersensitivity, neuroinflammatory responses, and synaptic plasticity in the mouse trigeminal brainstem. J Neuroinflammation. 2019;16(1):268. doi:10.1186/s12974-019-1656-431847868
   PubMed Web of Science ®Google Scholar
• Giannaccare G, Pellegrini M, Sebastiani S, Moscardelli F, Versura P, Campos EC. In vivo confocal microscopy morphometric analysis of corneal subbasal nerve plexus in dry eye disease using newly developed fully automated system. Graefes Arch Clin Exp Ophthalmol. 2019;257(3):583–589. doi:10.1007/s00417-018-04225-730637452
   PubMed Web of Science ®Google Scholar
• Rahman EZ, Lam PK, Chu C-K, Moore Q, Pflugfelder SC. Corneal sensitivity in tear dysfunction and its correlation with clinical parameters and blink rate. Am J Ophthalmol. 2015;160(5):858–866.e855. doi:10.1016/j.ajo.2015.08.00526255576
   PubMed Web of Science ®Google Scholar
• Shen F, Dong X, Zhou X, Yan L, Wan Q. Corneal subbasal nerve plexus changes in patients with episodic migraine: an in vivo confocal microscopy study. J Pain Res. 2019;12:1489–1495. doi:10.2147/JPR.S19670531190959
   PubMed Web of Science ®Google Scholar
• Shetty R, Deshmukh R, Shroff R, Dedhiya C, Jayadev C. Subbasal nerve plexus changes in chronic migraine. Cornea. 2018;37(1):72–75. doi:10.1097/ICO.000000000000140328990996
   PubMed Web of Science ®Google Scholar
• Aykut V, Elbay A, Esen F, Kocaman G, Savran Elibol E, Oguz H. Patterns of altered corneal sensation in patients with chronic migraine. Eye Contact Lens. 2018;44:S400–S403. doi:10.1097/ICL.000000000000055330256232
   PubMed Web of Science ®Google Scholar
• Burstein R, Jakubowski M, Garcia-Nicas E, et al. Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol. 2010;68(1):81–91. doi:10.1002/ana.2199420582997
   PubMed Web of Science ®Google Scholar
• Crane AM, Feuer W, Felix ER, et al. Evidence of central sensitisation in those with dry eye symptoms and neuropathic-like ocular pain complaints: incomplete response to topical anaesthesia and generalised heightened sensitivity to evoked pain. Br J Ophthalmol. 2017;101(9):1238–1243. doi:10.1136/bjophthalmol-2016-30965828100479
   PubMed Web of Science ®Google Scholar
• Gomes JAP, Azar DT, Baudouin C, et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017;15(3):511–538.28736341
   PubMed Web of Science ®Google Scholar
• Filippi M, Messina R. The chronic migraine brain: what have we learned from neuroimaging? Front Neurol. 2020;10:1356. doi:10.3389/fneur.2019.0135631998217
   PubMed Web of Science ®Google Scholar
• Chen Z, Chen X, Liu M, Dong Z, Ma L, Yu S. Altered functional connectivity of amygdala underlying the neuromechanism of migraine pathogenesis. J Headache Pain. 2017;18(1):7. doi:10.1186/s10194-017-0722-528116559
   PubMed Web of Science ®Google Scholar
• Lee MJ, Park B-Y, Cho S, Kim ST, Park H, Chung C-S. Increased connectivity of pain matrix in chronic migraine: a resting-state functional MRI study. J Headache Pain. 2019;20(1):29. doi:10.1186/s10194-019-0986-z30909865
   PubMed Web of Science ®Google Scholar
• Hegarty DM, Hermes SM, Morgan MM, Aicher SA. Acute hyperalgesia and delayed dry eye after corneal abrasion injury. Pain Rep. 2018;3(4):e664–e664. doi:10.1097/PR9.000000000000066430123857
   PubMedGoogle Scholar
• Toker E, Asfuroglu E. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy. Cornea. 2010;29(2):133–140. doi:10.1097/ICO.0b013e3181acf68d19966564
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Y, Tian K, et al. Calcitonin gene-related peptide facilitates sensitization of the vestibular nucleus in a rat model of chronic migraine. J Headache Pain. 2020;21(1):72. doi:10.1186/s10194-020-01145-y32522232
   PubMed Web of Science ®Google Scholar
• Zhang X, Levy D, Kainz V, Noseda R, Jakubowski M, Burstein R. Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol. 2011;69(5):855–865. doi:10.1002/ana.2232921416489
   PubMed Web of Science ®Google Scholar
• Melo-Carrillo A, Noseda R, Nir -R-R, et al. Selective inhibition of trigeminovascular neurons by fremanezumab: a humanized monoclonal anti-CGRP antibody. J Neurosci. 2017;37(30):7149–7163. doi:10.1523/JNEUROSCI.0576-17.201728642283
   PubMed Web of Science ®Google Scholar
• Christensen CE, Younis S, Deen M, Khan S, Ghanizada H, Ashina M. Migraine induction with calcitonin gene-related peptide in patients from erenumab trials. J Headache Pain. 2018;19(1):105. doi:10.1186/s10194-018-0927-230409109
   PubMed Web of Science ®Google Scholar
• Urits I, Jones MR, Gress K, et al. CGRP antagonists for the treatment of chronic migraines: a comprehensive review. Curr Pain Headache Rep. 2019;23(5):29. doi:10.1007/s11916-019-0768-y30874961
   PubMed Web of Science ®Google Scholar
• Mason BN, Kaiser EA, Kuburas A, et al. Induction of migraine-like photophobic behavior in mice by both peripheral and central CGRP mechanisms. J Neurosci. 2017;37(1):204–216. doi:10.1523/JNEUROSCI.2967-16.201628053042
   PubMed Web of Science ®Google Scholar
• Rea BJ, Wattiez A-S, Waite JS, et al. Peripherally administered calcitonin gene-related peptide induces spontaneous pain in mice: implications for migraine. Pain. 2018;159(11):2306–2317. doi:10.1097/j.pain.000000000000133729994995
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Kheirkhah A, Cavalcanti BM, Cruzat A, Jamali A, Hamrah P. Correlation of corneal immune cell changes with clinical severity in dry eye disease: an in vivo confocal microscopy study. Ocul Surf. 2020;19:183–189. doi:10.1016/j.jtos.2020.05.01232504855
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Ibrahim OMA. Application of in vivo confocal microscopy in dry eye disease. Invest Ophthalmol Vis Sci. 2018;59(14):DES41–DES47. doi:10.1167/iovs.17-2360230481805
   PubMed Web of Science ®Google Scholar
• Moein H-R, Akhlaq A, Dieckmann G, et al. Visualization of microneuromas by using in vivo confocal microscopy: an objective biomarker for the diagnosis of neuropathic corneal pain? Ocul Surf. 2020;18(4):651–656. doi:10.1016/j.jtos.2020.07.00432663518
   PubMed Web of Science ®Google Scholar
• Stepp MA, Pal-Ghosh S, Downie LE, et al. Corneal epithelial “neuromas”: a case of mistaken identity? Cornea. 2020;39(7):930–934. doi:10.1097/ICO.000000000000229432118667
   PubMed Web of Science ®Google Scholar
• Dermer H, Hwang J, Mittal R, Cohen A, Galor A. Corneal sub-basal nerve plexus microneuromas in individuals with and without dry eye. Br J Ophthalmol. 2021;bjophthalmol-2020-317891. doi:10.1136/bjophthalmol-2020-317891
   Web of Science ®Google Scholar
• Spierer O, Felix ER, McClellan AL, et al. Corneal mechanical thresholds negatively associate with dry eye and ocular pain symptoms. Invest Ophthalmol Vis Sci. 2016;57(2):617–625. doi:10.1167/iovs.15-1813326886896
   PubMed Web of Science ®Google Scholar
• Silbert JA, Bitton E, Bhagat K. Advances in diagnosis and management of dry eye disease. Adv Ophthalmol Optom. 2019;4:13–38. doi:10.1016/j.yaoo.2019.04.002
   Google Scholar
• Dieckmann G, Goyal S, Hamrah P. Neuropathic corneal pain: approaches for management. Ophthalmology. 2017;124(11):S34–s47. doi:10.1016/j.ophtha.2017.08.00429055360
   PubMed Web of Science ®Google Scholar
• Ong JJY, De Felice M. Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics. 2018;15(2):274–290. doi:10.1007/s13311-017-0592-129235068
   PubMed Web of Science ®Google Scholar
• Kheirkhah A, Dohlman TH, Amparo F, et al. Effects of corneal nerve density on the response to treatment in dry eye disease. Ophthalmology. 2015;122(4):662–668. doi:10.1016/j.ophtha.2014.11.00625542519
   PubMed Web of Science ®Google Scholar
• Konstantinos S, Vikelis M, Rapoport A. Acute care and treatment of migraine. J Neuro Ophthalmol. 2020;40(4):472–484. doi:10.1097/WNO.0000000000001053
   Web of Science ®Google Scholar
• Small LR, Galor A, Felix ER, Horn DB, Levitt RC, Sarantopoulos CD. Oral gabapentinoids and nerve blocks for the treatment of chronic ocular pain. Eye Contact Lens. 2020;46(3):174–181. doi:10.1097/ICL.000000000000063031206369
   PubMed Web of Science ®Google Scholar
• Ozmen MC, Dieckmann G, Cox SM, et al. Efficacy and tolerability of nortriptyline in the management of neuropathic corneal pain. Ocul Surf. 2020;18(4):814–820. doi:10.1016/j.jtos.2020.08.00632860971
   PubMed Web of Science ®Google Scholar
• Janis JE, Barker JC, Palettas M. Targeted peripheral nerve-directed onabotulinumtoxin A injection for effective long-term therapy for migraine headache. Plast Reconstr Surg Glob Open. 2017;5(3):e1270. doi:10.1097/GOX.000000000000127028458982
   PubMedGoogle Scholar
• Herd CP, Tomlinson CL, Rick C, et al. Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine. BMJ Open. 2019;9(7):e027953. doi:10.1136/bmjopen-2018-027953
   PubMed Web of Science ®Google Scholar
• Diel RJ, Kroeger ZA, Levitt RC, et al. Botulinum toxin A for the treatment of photophobia and dry eye. Ophthalmology. 2018;125(1):139–140. doi:10.1016/j.ophtha.2017.09.03129110944
   PubMed Web of Science ®Google Scholar
• Venkateswaran N, Hwang J, Rong AJ, et al. Periorbital botulinum toxin A improves photophobia and sensations of dryness in patients without migraine: case series of four patients. Am J Ophthalmol Case Rep. 2020;19:100809. doi:10.1016/j.ajoc.2020.10080932671286
   PubMedGoogle Scholar
• Tao H, Wang T, Dong X, Guo Q, Xu H, Wan Q. Effectiveness of transcutaneous electrical nerve stimulation for the treatment of migraine: a meta-analysis of randomized controlled trials. J Headache Pain. 2018;19(1):42. doi:10.1186/s10194-018-0868-929845369
   PubMed Web of Science ®Google Scholar
• Zayan K, Aggarwal S, Felix E, Levitt R, Sarantopoulos K, Galor A. Transcutaneous electrical nerve stimulation for the long-term treatment of ocular pain. Neuromodulation. 2020;23(6):871–877. doi:10.1111/ner.1314632196838
   PubMed Web of Science ®Google Scholar
• Shauly O, Gould DJ, Sahai-Srivastava S, Patel KM. Greater occipital nerve block for the treatment of chronic migraine headaches: a systematic review and meta-analysis. Plast Reconstr Surg. 2019;144(4):943–952. doi:10.1097/PRS.000000000000605931568309
   PubMed Web of Science ®Google Scholar
• Cady R, Saper J, Dexter K, Manley HR. A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360((R)) as acute treatment for chronic migraine. Headache. 2015;55(1):101–116. doi:10.1111/head.1245825338927
   PubMed Web of Science ®Google Scholar
• Mehta D, Leary MC, Yacoub HA, et al. The effect of regional anesthetic sphenopalatine ganglion block on self-reported pain in patients with status migrainosus. Headache. 2019;59(1):69–76. doi:10.1111/head.1339030043973
   PubMed Web of Science ®Google Scholar
• Chen W, Batawi HIM, Alava JR, et al. Bulbar conjunctival microvascular responses in dry eye. Ocul Surf. 2017;15(2):193–201. doi:10.1016/j.jtos.2016.12.00228042094
   PubMed Web of Science ®Google Scholar